Core Insights - SG Capital Management LLC reduced its holding in Haemonetics Corporation by 731,892 shares, resulting in a position value decline of approximately $59.1 million as of November 7, 2025 [1][2]. Company Overview - Haemonetics Corporation is a leading provider of medical devices and software for blood and plasma management, addressing critical needs in transfusion medicine and plasma collection through a diversified product portfolio and integrated technology platforms [5][6]. - The company generates revenue primarily from the sale of medical devices, disposables, and integrated software solutions to healthcare providers and plasma collection centers globally [6]. Financial Performance - For the trailing twelve months (TTM), Haemonetics reported revenue of $1.33 billion and net income of $168.19 million [4]. - The company's share price as of November 6, 2025, was $67.11, reflecting a 14.14% decline over the past year, underperforming the S&P 500 by 27.5 percentage points [4][10]. Recent Developments - Haemonetics reported a 5% decline in revenue for the fiscal second quarter, totaling $327 million, with a 1.8% drop when excluding foreign-currency exchange impacts and divestitures [8]. - Management's guidance for the full year's adjusted revenue indicates a potential decline of 1% to an increase of 2%, which is an improvement from previous guidance [9]. Investment Activity - Following the reduction in its stake, Haemonetics now accounts for only 0.8% of SG Capital's total 13F assets under management (AUM), down from 4.7% in the prior quarter [10]. - The market reacted positively to Haemonetics' results and guidance, with the share price increasing by 35% in the two days following the earnings release [11].

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Franklin Wireless Corp. (NASDAQ: FKWL) today announced that its Board of Directors has approved a one-time special dividend of $0.04 per share. The dividend will be payable on December 2, 2025, to shareholders of record as of the close of business on November 14, 2025. “The Board’s approval of this special dividend reflects our ongoing commitment to creating value for shareholders. We thank our investors for their continued confidence and support,” said OC Kim, P ...